Economic Evaluation of Dasatinib Compared To Nilotinib as...

Value in Health 2017 / 10 Vol. 20; Iss. 9

Economic Evaluation of Dasatinib Compared To Nilotinib as Second Line Treatment of Chronic Myeloid Leukemia in Greece

Gourzoulidis, G, Vassilopoulos, G, Gialama, F, Kourlaba, G, Diamantogiannis, F, Maniadakis, N
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.257
Date:
October, 2017
File:
PDF, 61 KB
english, 2017
Conversion to is in progress
Conversion to is failed